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ABSTRACT 
Background: Influenza B virus has been perceived to cause less disease burden and milder 
disease when compared to influenza A, but recent studies suggest influenza B does have a 
significant impact. We aimed to estimate the burden of influenza B virus infections on 
hospitalizations in Hong Kong, in the context of virus lineage changes over time. 
Methods: The pediatric age-specific rates of influenza B hospitalization in Hong Kong for 
2004-2014 were estimated based on admissions to two hospitals that together catered for 
72.5% of all pediatric admissions on Hong Kong Island. Influenza B virus was detected by 
immunofluorescence and culture on nasopharyngeal aspirates. Lineage typing was performed 
by RT-PCR. 
Results: A total of 5085 children were recruited on one designated day each week, year-
round during the 11 years, and 221 (4.3%) tested positive for influenza B. Hospitalization 
rates were highest in children aged 2-<5 years with year to year variation. Victoria-lineage 
viruses appeared to be associated with a greater fraction of influenza B hospitalizations in 
children than of influenza B infections in the general community. Influenza B did not cause 
significant hospitalization in infants <1 year of age. 
Conclusions: We report one of the first population-based age-specific and lineage-specific 
studies of pediatric hospitalization for influenza B. We found that changes in lineage were 
associated with higher hospitalization rates and we documented that Victoria lineage viruses 
were associated with greater pediatric hospitalization burden compared with Yamagata 
lineage viruses.  
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INTRODUCTION 
Influenza leads to a significant burden of hospitalization in children annually. Influenza B 
was first identified in 1940 and two antigenically distinct virus lineages emerged in the mid-
1980s, designated as the B/Yamagata and B/Victoria lineages [1]. Influenza B has been 
perceived to be associated with a lower disease burden and milder disease when compared to 
influenza A, but some recent studies have suggested that influenza B also causes significant 
mortality and morbidity [2,3]. Most studies on influenza B burden have not been able to 
estimate population-based incidence but are reports on frequencies of hospital admissions 
without defined population denominators. We previously published a study encompassing the 
influenza seasons of 2003-04 to 2005-06 that documented year to year variations in influenza 
B hospitalization [4]. In the current study, we report the age-specific hospitalization disease 
burden of influenza B in children in Hong Kong over an 11-year period.   
 
METHODS 
Study design 
The Hong Kong Special Administrative Region (SAR) of China comprises of Hong Kong 
Island, Kowloon peninsular, the New Territories and some sparsely populated outlying 
islands. In 2006, there were 195,922 persons <18 years of age residing on Hong Kong Island 
[4]. Pamela Youde Nethersole Eastern Hospital and Queen Mary Hospital were the only two 
acute public hospitals on Hong Kong Island serving this population. These two hospitals, 
with a total of 153 pediatric beds, catered for 72.5% of all pediatric admissions from the 
population of Hong Kong Island in 2006 [4] (the remainder being admitted to private 
hospitals). While Hong Kong Island is not an entirely closed community, parents from other 
parts of Hong Kong SAR, namely Kowloon and the New Territories, rarely bring their 
children across the harbor for acute general pediatric problems since there are 10 public 
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hospitals with pediatric inpatient service serving those areas. Thus admissions can be related 
to the pediatric population resident on Hong Kong Island, allowing us to derive population 
based estimates of influenza associated hospitalization burden [4,5].  
 
Acute respiratory infection was defined as fever ≥38°C (by history or documentation on 
admission) with any respiratory symptom including cough, runny nose, or sore throat. A 
systematic sample of all hospital admissions was derived by recruiting all patients aged <18 
years of age with a Hong Kong Island home address admitted to either study hospital with 
acute respiratory infection during one designated day (24 consecutive hours) of the week. All 
recruited patients had a nasopharyngeal aspirate (NPA) specimen collected for virological 
testing.  
 
The study protocol was approved by the joint Institutional Review Board of the University of 
Hong Kong and the Hospital Authority Hong Kong West Cluster, and the Hospital Authority 
Hong Kong East Cluster Research Ethics Committee which waived the need for written 
consent since the investigation was a routine diagnostic test carried out as part of routine care, 
and patient information was delinked from individual patient identification to maintain 
patient confidentiality. 
 
Laboratory methods 
NPA specimens from all recruited patients were tested for influenza B virus by direct antigen 
detection by direct immunofluorescence (IF) test, and by virus culture, at the Virology 
Laboratory at the University of Hong Kong and the Public Health Laboratory Services 
Branch, Centre for Health Protection, Department of Health, respectively. The direct 
immunofluorescence antigen test was carried out as previously described using IMAGENTM 
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respiratory screen and typing reagents (Oxoid Ely Ltd., UK)  [6]. All the specimens found 
positive in the respiratory screen with a pooled IF reagent were further identified using 
antibody reagents to influenza B using the IMAGENTM typing kit. 
 
Culture for respiratory viruses was done by inoculation 150 µl of the nasopharyngeal 
aspirate-virus transport medium suspension onto monolayers of continuous cell lines, 
including Martin Darby Canine Kidney (MDCK), African Green Monkey kidney (LLC-
MK2), human epidermoid laryngngeal carcinoma (HEp-2C) and human embryonal 
rhabdomyosarcoma (RD), in culture tubes at the virology laboratory of the Department of 
Health as previously described [7]. This laboratory is the designated National Influenza 
Centre for Hong Kong within the World Health Organization (WHO) influenza laboratory 
network. MDCK was the cell line used for influenza virus isolation and inoculated cells were 
maintained in serum free medium with trypsin (2 µg/ml), and incubated at 33°C for 7 days. 
The cultures were examined daily for cytopathic effect and IF and hemagglutination 
inhibition tests were used for identification and antigenic characterization of influenza viruses 
respectively. 
 
Influenza B lineages were differentiated by real-time PCR as described previously with 
modification [8]. Briefly, reaction conditions were established for the LightCycler 96 system 
in a total reaction mixture volume of 25 l containing 1X reaction mix (Invitrogen), 0.5 U 
SuperScriptIII Platinum RT Taq polymerase (Invitrogen), 900 nM forward primer (5-
ACCCTACAR AMTTGGAACYTCAGG-3 ), 600 nM reverse primer (5-
ACAGCCCAAGCCATTGTTG-3 ), 150 nM Yamagata probe MGB437 (5-FAM–
AATCCGMTYTTACTGGTAG–MGB-3 ), 100 nM Victoria probe MGB470 (5-VIC–
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ATCCGTTTCCATTGGTAA–MGB-3), and 5 l of RNA. Cycling conditions were 30 min at 
50°C,then 2 min at 95°C, and followed by 50 cycles of 15 s at 95°C and 30 s at 55°C. 
 
For comparison, we also obtained data on the community circulation of influenza B virus 
lineages in Hong Kong based on laboratory surveillance done by the virology laboratory of 
the Department of Health. In these surveillance data, approximately 95% of the positive 
results are detected from specimens from adult and pediatric patients hospitalized in public 
and private hospitals, the remainder are from out-patient clinics. 
 
Statistical analysis 
Hospitalization rates and 95% confidence intervals for each age group were estimated using 
Poisson regression models. The numerator in each incidence rate was the number of 
laboratory-confirmed influenza admissions in that age group, while the denominator was the 
estimated person-years at risk each year and was included in regression models as an offset 
term. The person-years at risk were estimated by the population of Hong Kong Island in that 
age group obtained from the Census and Statistics Department of the Hong Kong government 
based on regular population censuses, divided by 7 to allow for the study design of sampling 
one day per week, and further divided by 0.725 to arrive at the proportion of children served 
by the two study hospitals. Census data for infants under 6 months were lacking. Therefore, 
we used half the population under 1 year of age as the denominator, assuming a constant birth 
rate over the year. Statistical analyses were conducted using SAS version 9.02 (SAS Institute, 
Cary, NC) and R version 2.15.1 (R Foundation for Statistical Computing, Vienna, Austria). 
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RESULTS 
A total of 5085 children were included in the entire study spanning 11 years. Two hundred 
and twenty one children (4.3%) were tested positive for influenza B. Among all the 
hospitalized patients infected with influenza B, only 11 were <12 months of age. Of 436 
infants <6 months, only four (0.9%) had influenza B virus infection when compared to 28 
(6.4%) with influenza A virus infection and 98 (22.5%) with respiratory syncytial virus (RSV) 
infection. Likewise, of the 629 infants 6-12 months of age, seven (1.1%) had influenza B 
virus infection while 36 (5.7%) had influenza A virus infection and 108 (17.2%) had RSV 
infection. Of the 4020 children >12 months of age, 210 (5.2%) had influenza B infection 
compared to 440 (10.9%) with influenza A and 326 (8.1%) with RSV infection. 
  
Of the 221 samples positive for influenza B, 175 were available for lineage analysis. Both 
lineages co-circulated in most years with the exception when a Yamagata lineage virus (in 
2004 and 2007) or a Victoria lineage virus (in 2006) accounted for ≥95% of influenza B 
viruses identified (Table 1). There was almost no influenza B circulation in Hong Kong in 
2009, the year when influenza A(H1N1pdm09) emerged. There was also very little influenza 
B circulation in 2013. In 2007, 2008, 2010, 2012 and 2014, influenza B circulation accounted 
for >3% of all respiratory samples from inpatients and outpatients tested by the government 
virology laboratory. There was no predictable seasonality with frequent overlap with that of 
influenza A. Influenza B caused hospitalization in almost all months in a few years (2007 and 
2010) (Figure 1). 
 
There was significant year to year fluctuation in disease burden in terms of pediatric 
hospitalizations due to influenza B in the 11 study years, largely correlating with influenza B 
circulation across the whole of Hong Kong (Figure 2A). Lineage-specific hospitalization 
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rates also fluctuated (Figure 2B). The proportion of children with chronic illness at high risk 
for influenza complications varied from year to year ranging from 11% to 38%. In general, 
hospitalization rates were consistently highest in children aged 2-<5 years and markedly 
higher in younger children below 2 years and older children 5-<10 years of age (Table 1). 
However, there was year to year variation. The rate of 38.7 per 10,000 in 2005 was 
significantly higher from that of 7.1 per 10,000 in 2004 (p=0.03) in the 2-<5 years group. 
There was also an apparent increase in hospitalizations in 2007 (65.6 per 10,000) when 
compared to 25.4 per 10,000 in 2006 and (p=0.06) in this age group when the predominant 
virus switched from a Victoria lineage virus to a Yamagata lineage virus. Influenza B did not 
appear to cause significant hospitalization in infants <1 year of age. Hospitalization in this 
age group was only documented in four of the 11 study years and all four years were 
dominated by circulation of the Yamagata lineage viruses after several years of Victoria 
lineage virus circulation.   
 
The Victoria-lineage virus appeared to be associated with excess hospitalization in children 
when hospitalization is plotted against proportion of Victoria lineage viruses in circulation 
each year (Figure 3). In all of the confirmed influenza B hospitalizations included in this 
study, the mean age of hospitalized children was 6.0 years for B/Victoria vs 4.5 years for 
B/Yamagata (p=0.007) (Figure 4). With the exception of 2012, no infant <12 months of age 
was hospitalized for Victoria lineage virus infection. 
 
DISCUSSION 
In this study, we documented age-specific rates of hospitalizations due to influenza B 
lineages in children over a period of 11 years. Disease burden in terms of influenza B  
hospitalizations varied from year to year and has to be interpreted within the context of 
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overall virus activity, the influenza B lineages in circulation in each year, the emergence of 
antigenically different viruses, and influenza vaccination coverage. Athough we did not have 
complete vaccination data on all the patients in the present study, in a previously reported 
vaccine effectiveness study conducted between 2009 and 2014, we reported that influenza 
vaccination coverage is very low in children in Hong Kong with 8.8% in those hospitalized 
for a respiratory illness other than influenza B receiving influenza vaccine [9]. Meanwhile, 
two previous studies reported that 1.7% and 3.9% of pregnant women in Hong Kong were 
vaccinated during their pregnancy [10,11]. Therefore, the impact of influenza vaccination on 
hospitalization disease burden documented in this study is likely to be minimal. 
 
It is commonly reported that influenza B mainly affects school aged children [12-14]. In this 
11-year study, we also documented significant population based hospitalization rates in 
children 5-<10 years of age, but hospitalization rates were highest in children 2-<5 years 
(Table 1). In an earlier study of  2004-05 we also documented the highest hospitalization 
rates in the 2-<5 year age group [4]. This may reflect that influenza B virus infections in the 
younger age group were more likely to result in hospitalization, either due to more severe 
disease or a lower admission threshold in this younger age group. In a 20-year retrospective 
study of pediatric inpatients and outpatients from Finland, Peltola et al. found that outpatient 
consultation and hospitalization were highest in children <2 years [15]. A population-based 
study for children under 6 years in the US indicated that the age group with the highest 
influenza hospital admissions was infants <6 months while influenza A viruses were 
predominant during the study period [16]. 
 
Interestingly, unlike influenza A that resulted in the highest hospitalization in the youngest 
age group [5], we found that influenza B caused much lower hospitalization rates in infants 
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<12 months of age. Specifically, hospitalization of infants <6 months was only seen in three 
of the 11 years (Table 1). This was also documented in the Tecumseh Study which found no 
influenza B virus infections in 43 infants <1 year of age and only one patient in 135 patients 
1-2 years of age (0.7%) [12]. Recently, a birth cohort study in Vietnam also showed that 
influenza B virus infection in infants <1y was rare [17]. Lineage characterization was not 
performed in these studies. The epidemiology of influenza B virus infections or 
hospitalization in this very young age is not well described in the literature because many 
influenza B studies focused on school age and older children. Protection from maternal 
antibodies may explain the very low incidence of influenza B hospitalization in these infants. 
Furthermore, the difference in hospitalization rates for influenza A and influenza B in very 
young infants may be explained by higher prevalence of protective maternal antibody against 
influenza B when compared to influenza A since influenza B viruses are believed to evolve 
more slowly than influenza A allowing for a higher background immunity against influenza 
B. In addition, there was hardly any hospitalization of infants <6 months of age due to 
Victoria lineage viruses even during a time of significant influenza B Victoria lineage 
circulation (Table 2). Unlike the rest of the world where the the Victoria lineages were not 
found between 1990s and early 2000, they have persisted in mainland China and Hong Kong 
since the 1980s [18,19]. Morevoer, Vijaykrishna et al. found that Victoria viruses were 
generally more transmissible than Yamagata viruses [20]. Thus it is likely that there would be 
a greater level of immunity to B/Victoria lineage viruses in women of child-bearing age in 
Hong Kong that may explain the low hospitalization rates in these young infants. Further 
studies to correlate maternal antibodies with infant infection of respective influenza B lineage 
would help to confirm this hypothesis.  
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Some previous studies have suggested that B/Victoria lineage viruses result in more 
infections or hospitalizations in the younger age groups (<15y) compared to B/Yamagata 
viruses in studies of all ages [19,21,22]. In this study of pediatric age groups, we provided 
age-specific rates and found that while the Victoria lineage viruses appears to cause higher 
rates of hospitalization, hospitalized children with B/Yamagata lineage viruses were in fact 
younger than those hospitalized with B/Victoria lineage viruses, and almost all 
hospitalizations in the <12 months group were attributed to B/Yamagata lineage viruses. 
Vijaykrishna et al. showed that Victoria lineage viruses have higher rates of antigenic drift, 
and expected the lower rates of antigenic drift of B/Yamagata lineage viruses to skew the age 
distribution of cases towards younger individuals after maternal antibody has waned [20]. 
Our study findings do support their hypothesis. A recent study from Bangkok did not 
compare hospitalization rates but concluded that the B/Victoria lineage viruses were 
associated with a longer duration of hospitalization, and a higher number of fatal cases and 
pneumonia [23]. However the study included all age groups with a trend towards a higher 
proportion of patients ≥65y in the B/Victoria lineage group.  
 
An example of the impact of a change in lineage predominance was observed in 2007. In that 
year, Hong Kong had substantial influenza B activity (Figure 1) and we documented 
significant pediatric hospitalization in all months except January that year [25]. Yamagata 
lineage virus dominated with 95% of influenza B in circulation in Hong Kong following 
2006 which was a year of Victoria lineage dominance (97%). The abrupt switch of lineage 
predominance may explain the high virus circulation and disease burden. The impact of 
emergence of a different clade could also be seen: in 2012, the Yamagata lineage viruses only 
accounted for 58% of influenza B in Hong Kong but there was an increase in hospitalization 
due to Yamagata lineage viruses including in infants 6-12 months of age that was not seen in 
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the previous two years (2010 and 2011) with similar ratio of Victoria to Yamagata lineage 
virus circulation (Table 2 and Figure 2). Although we did not perform antigenic analysis on 
the strains from our individual patients, WHO reported the emergence of clade 2 Yamagata 
lineage viruses that were antigenically different from the previously circulating clade 3 
(B/Wisconsin/1/2010 Yam-like) viruses [26]. Again, in 2014, Yamagata lineage viruses 
accounted for 86% of influenza B viruses in Hong Kong and resulted in moderately high 
hospitalization rates in children. This might be due to the circulation of clade 3 viruses that 
were antigenically distinguishable from the vaccine strain B/Massachusetts/2/2012 which 
was a clade 2 virus [27]. Clade analysis on 30 Yamagata lineage viruses in that year showed 
that 27 indeed belonged to clade 3 (Lo et al. unpublished data). 
 
There are a number of limitations to our study. Our study is based on children hospitlised 
with influenza B and we have no information on influenza B circulation in children in the 
general community. We included children who met our case definition of fever (or history of 
fever) plus at least one respiratory symptom and therefore may have excluded a small number 
of influenza B hospitalizations with atypical presentation. Furthermore, we do not have 
antigenic characterization of the individual strains from patients. However, viral circulation 
and antigenic analysis derived from the overall surveillance data in Hong Kong from the 
Department of Health provides some indication of viruses, lineages and antigenic variants 
circulating in the Hong Kong community overall. 
 
In conclusion, we report one of the first population-based studies of pediatric hospitalization 
for influenza B by lineage. We found that hospitalization rates varied from year to year, 
largely corresponding to overall virus circulation within the community. We found that 
higher hospitalization rates correlated with changes in lineage. We documented that Victoria 
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lineage viruses were associated with greater excess hospitalization than might have been 
expected based on the proportion of viruses in circulation within the community (Figure 3). 
This study highlights the importance of interpreting influenza B disease burden in the context 
of antigenic changes and background viral activity.  
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FIGURE LEGENDS 
 
Figure 1. Rates of hospitalization associated with influenza B in children <18 years of age by 
calendar month from 2004-2014. Hospitalization rates for influenza A over the same period 
are also presented for comparison. 
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Figure 2. Annual hospitalization rates of paediatric patients infected with influenza B viruses 
overall (panel A), and identified as Victoria or Yamagata lineage (panel B) in Hong Kong 
from 2004 through 2014. An asterisk above particular estimates indicates the year when there 
was an antigenic change in the corresponding lineage. The bottom row reports the annual 
proportion of laboratory detections of influenza B cases belonging to Victoria lineage among 
all influenza B detections with lineage typing done. The proportions of laboratory detections 
of influenza B/Yamagata lineage virus among all influenza B detections can be calculated as 
one minus the proportion of B/Victoria detections, and are therefore not shown. 
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Figure 3. Association between the proportion of influenza B hospitalizations in children 
associated with B/Victoria viruses (y-axis) and the proportion of community detections of 
influenza B associated with B/Victoria viruses (x-axis) each year. Note that the proportion of 
B/Yamagata can be derived as one minus the proportion with B/Victoria. The two digits 
indicate the corresponding year in the 21st century, e.g. 09 corresponds to the calendar year of 
2009. Points above the diagonal line indicate years in which the B/Victoria viruses were 
identified more frequently in hospitalized children with influenza B than among influenza B 
infections in the community. Points below the diagonal line indicate years in which the 
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B/Yamagata viruses were identified more frequently in hospitalized children with influenza B 
than among influenza B infections in the community. 
 
 
 
Figure 4. Age distribution of pediatric hospitalizations associated with B/Victoria and 
B/Yamagata lineage viruses. 
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Table 1. Age-specific rates of hospitalizations (95% confidence interval)  associated with confirmed influenza B Yamagata or Victoria lineage per 10,000 
residents, 2004-2011  
 
Year 
Predominant 
Lineage 
in Hong Kong 
(%) 
<6m 6-12m 1-<2y 2-<5y 5-<10y 10-<15y 15-<18y 
B / 
Yamagata 
B / 
Victoria B / Yamagata 
B / 
Victoria 
B / 
Yamagata 
B / 
Victoria 
B / 
Yamagata 
B / 
Victoria 
B / 
Yamagata 
B / 
Victoria 
B / 
Yamagata 
B / 
Victoria 
B / 
Yamagata 
B / 
Victoria 
2004 97% (Yam)-like 0 
(0, 86.7) 
0 
(0, 86.7) 
0 
(0, 86.7) 
0 
(0, 86.7) 
0 
(0, 44.4) 
0 
(0, 44.4) 
7.1 
(0.9, 25.7) 
0 
(0, 13.1) 
6.5 
(1.8, 16.6) 
1.6 
(0, 9.0) 
0 
(0, 5.2) 
0 
(0, 5.2) 
0 
(0, 8.8) 
0 
(0, 8.8) 
2005 72% (Yam)-like 0 
(0, 91.1) 
0 
(0, 91.1) 
0 
(0, 91.1) 
0 
(0, 91.1) 
12.8 
(0.3, 71.4) 
12.8 
(0.3, 71.4) 
19.4 
(6.3, 45.2) 
7.7 
(0.9, 28.0) 
3.4 
(0.4, 12.4) 
0 
(0, 6.3) 
0 
(0, 5.3) 
4.3 
(0.9, 12.6) 
0 
(0, 8.9) 
2.4 
(0.1, 13.4) 
2006 96% (Vic)-like 0 
(0, 95.7) 
0 
(0, 95.7) 
0 
(0, 95.7) 
0 
(0, 95.7) 
0 
(0, 50.3) 
0 
(0, 50.3) 
0 
(0, 15.6) 
25.4 
(9.3, 55.3) 
0 
(0, 6.7) 
14.5 
(6.3, 28.7) 
0 
(0, 5.4) 
2.9 
(0.4, 10.6) 
0 
(0, 9.0) 
2.4 
(0.1, 13.6) 
2007 95% (Yam)-like 24.6 
(0.6, 136.8) 
0 
(0, 90.6) 
49.1 
(5.9, 177.4) 
0 
(0, 90.6) 
26.1 
(3.2, 94.4) 
13.1 
(0.3, 72.8) 
32.8 
(14.2, 64.6) 
0 
(0, 15.1) 
11.5 
(4.2, 25.0) 
0 
(0, 7.1) 
1.5 
(0, 8.5) 
0 
(0, 5.6) 
0 
(0, 9.1) 
0 
(0, 9.1) 
2008 72% (Yam)-like 0 
(0, 86.2) 
0 
(0, 86.2) 
23.4 
(0.6, 130.2) 
0 
(0, 86.2) 
12.6 
(0.3, 70.0) 
0 
(0, 46.4) 
12.0 
(2.5, 34.9) 
8.0 
(1.0, 28.8) 
6.1 
(1.3, 17.7) 
6.1 
(1.3, 17.7) 
0 
(0, 5.9) 
1.6 
(0, 8.9) 
2.5 
(0.1, 14.1) 
0 
(0, 9.3) 
2009 59% (Vic)-like 0 
(0, 82.5) 
0 
(0, 82.5) 
0 
(0, 82.5) 
0 
(0, 82.5) 
0 
(0, 44.8) 
12.2 
(0.3, 67.7) 
0 
(0, 14.4) 
0 
(0, 14.4) 
0 
(0, 8.0) 
2.2 
(0.1, 12.0) 
0 
(0, 6.2) 
0 
(0, 6.2) 
0 
(0, 9.5) 
0 
(0, 9.5) 
2010 69% (Vic)-like 0 
(0, 78.8) 
0 
(0, 78.8) 
0 
(0, 78.8) 
0 
(0, 78.8) 
0 
(0, 43.2) 
11.7 
(0.3, 65.2) 
3.8 
(0.1, 21.1) 
7.6 
(0.9, 27.3) 
2.3 
(0.1, 12.8) 
16.1 
(6.5, 33.1) 
0 
(0, 6.6) 
5.3 
(1.1, 15.6) 
0 
(0, 9.7) 
0 
(0, 9.7) 
2011 57% (Vic)-like 0 
(0, 75.4) 
0 
(0, 75.4) 
0 
(0, 75.4) 
0 
(0, 75.4) 
0 
(0, 41.7) 
0 
(0, 41.7) 
0 
(0, 13.6) 
22.1 
(8.1, 48.1) 
2.5 
(0.1, 13.7) 
14.7 
(5.4, 32.1) 
0 
(0, 6.9) 
1.9 
(0, 10.5) 
0 
(0, 9.9) 
0 
(0, 9.9) 
2012 59% (Yam)-like 0 
(0, 72.0) 
19.5 
(0.5, 108.7) 
39.0 
(4.7, 140.9) 
19.5 
(0.5, 108.7) 
10.9 
(0.3, 60.5) 
21.7 
(2.6, 78.5) 
32.1 
(14.7, 61.0) 
32.1 
(14.7, 61.0) 
21.0 
(9.1, 41.4) 
10.5 
(2.9, 26.9) 
2.0 
(0.1, 11.0) 
2.0 
(0.1, 11.0) 
0 
(0, 10.0) 
0 
(0, 10.0) 
2013 68% (Yam)-like 18.8 
(0.5, 104.6) 
0 
(0, 69.3) 
0 
(0, 69.3) 
0 
(0, 69.3) 
0 
(0, 38.8) 
0 
(0, 38.8) 
10.5 
(2.2, 30.6) 
0 
(0, 12.9) 
5.7 
(0.7, 20.6) 
5.7 
(0.7, 20.6) 
2.1 
(0.1, 11.8) 
2.1 
(0.1, 11.8) 
0 
(0, 10.3) 
0 
(0, 10.3) 
2014 78% (Yam)-like 0 
(0, 66.6) 
0 
(0, 66.6) 
0 
(0, 66.6) 
0 
(0, 66.6) 
10.2 
(0.3, 56.7) 
10.2 
(0.3, 56.7) 
10.2 
(2.1, 29.8) 
6.8 
(0.8, 24.6) 
18.6 
(6.8, 40.4) 
15.5 
(5.0, 36.1) 
2.3 
(0.1, 12.6) 
2.3 
(0.1, 12.6) 
0 
(0, 10.5) 
0 
(0, 10.5) 
